Literature DB >> 11162137

Nitric oxide activates the sarcolemmal K(ATP) channel in normoxic and chronically hypoxic hearts by a cyclic GMP-dependent mechanism.

J E Baker1, S J Contney, R Singh, B Kalyanaraman, G J Gross, Z J Bosnjak.   

Abstract

Chronic myocardial hypoxia results in elevated nitric oxide (NO) production and increased current through the sarcolemmal K(ATP) channel. We hypothesized these two processes are related and determined whether NO alters the electrophysiology of Purkinje fibers obtained from rabbits (n=12/group) raised in a normoxic (F(I)O2=0.21) or hypoxic (F(I)O2=0.12) environment from birth to 9 days of age. Action potential duration (APD)(90) was shorter (112+/-3 ms v 126+/-3 ms) and maximum diastolic potential (MDP) was more negative (-84+/-2 mV v-80+/-1 mV) in hypoxic hearts compared with normoxic controls. In normoxic hearts the NO donors, S-nitrosoglutathione (GSNO) 50 microM and spermine NONOate (50 microM) shortened APD(90) and increased MDP to levels present in chronically hypoxic hearts. This effect was completely abolished by the K(ATP) channel blocker glibenclamide (3 microM) and by a nitric oxide trap, Carboxy-PTIO (100 microM). The NO carrier glutathione (50 microM) and decomposed spermine NONOate had no effect on APD(90) or MDP. GSNO had no effect in hypoxic hearts; however, when GSNO was combined with glibenclamide APD(90) increased, and MDP decreased to normoxic values. 8-Bromo cGMP (100 microM) shortened APD(90) and increased MDP to levels present in chronically hypoxic hearts. This effect was abolished by glibenclamide. A soluble guanylyl cyclase inhibitor, ODQ (10 microM), had no effect on action potentials in normoxic hearts but in hypoxic hearts resulted in an increase in APD(90) to levels present in normoxic hearts and a decrease in MDP. The effect of ODQ could not be reversed by GSNO. We conclude that NO activates the sarcolemmal K(ATP) channel in normoxic and chronically hypoxic hearts by a cyclic GMP-dependent mechanism. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162137     DOI: 10.1006/jmcc.2000.1305

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

1.  Metabolic characteristics of immature myocardium.

Authors:  Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

Review 2.  Cardioprotective effects of nitrite during exercise.

Authors:  John W Calvert
Journal:  Cardiovasc Res       Date:  2010-09-27       Impact factor: 10.787

3.  Relationship between basal nitric oxide and ventricular repolarization in an intact heart.

Authors:  Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2003

4.  Long-Standing Cyanosis in Congenital Heart Disease Does not Cause Diffuse Myocardial Fibrosis.

Authors:  Ahmed Kharabish; Christian Meierhofer; Martin Hadamitzky; Jonathan Nadjiri; Stefan Martinoff; Peter Ewert; Heiko Stern
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

5.  Tolerance of the developing cyanotic heart to ischemia-reperfusion injury in the rat.

Authors:  Yasuhiro Fujii; Kozo Ishino; Tomoko Tomii; Hitoshi Kanamitsu; Hideya Mitsui; Shunji Sano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

6.  Ischemic injury of the developing heart.

Authors:  Bohuslav Ost'ádal; Ivana Ost'ádalová; L Skárka; F Kolár; Jan Kopecký
Journal:  Exp Clin Cardiol       Date:  2002

7.  Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.

Authors:  Dai-Min Zhang; Yongping Chai; Jeffrey R Erickson; Joan Heller Brown; Donald M Bers; Yu-Fung Lin
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

8.  Molecular mechanisms in exercise-induced cardioprotection.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  Cardiol Res Pract       Date:  2011-03-06       Impact factor: 1.866

9.  Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium.

Authors:  Giuseppina Milano; Paola Bianciardi; Viviane Rochemont; Giuseppe Vassalli; Ludwig K von Segesser; Antonio F Corno; Marco Guazzi; Michele Samaja
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

10.  Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia.

Authors:  Coline Nydegger; Carla Martinelli; Fabiano Di Marco; Gaetano Bulfamante; Ludwig von Segesser; Piergiorgio Tozzi; Michele Samaja; Giuseppina Milano
Journal:  Front Physiol       Date:  2018-03-27       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.